吉林敖东：控股子公司获25个中药配方颗粒上市备案凭证

Core Viewpoint - Jilin Aodong (000623) announced that its subsidiary Yanbian Pharmaceutical has obtained 25 listings for traditional Chinese medicine formula granules, which will positively impact the company's expansion in this business segment and enhance its core competitiveness [1] Group 1: Company Developments - Yanbian Pharmaceutical has received a total of 525 listing certificates for traditional Chinese medicine formula granules as of the announcement date [1] - The newly obtained products include Jiu Bi Ying, American ginseng, Huoxiang, and fried rice sprouts [1] Group 2: Market Impact - The sales performance of the newly listed products may be influenced by changes in the market environment, indicating potential uncertainties [1] - The short-term impact on the company's overall performance is not expected to be significant [1]